Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06266364 · ClinicalTrials.gov registry record · NA
Targeted Plasticity Therapy for PTSD
A NA study of PTSD - Post Traumatic Stress Disorder, sponsored by The University of Texas at Dallas.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 3
- Study locations
NCT06266364: Recruiting NA study of PTSD - Post Traumatic Stress Disorder, sponsored by The University of Texas at Dallas.
NCT06266364 is a NA study of PTSD - Post Traumatic Stress Disorder that is actively recruiting participants, run by The University of Texas at Dallas. The registered enrollment target is 20 participants, below the 278-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06266364, a NA study of PTSD - Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by The University of Texas at Dallas.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 3
- Study locations
Study Summary
Objectives of this study are to provide continued safety assessment for the ReStore system, and to gain further estimates of the effect size of Vagus Nerve Stimulation (VNS) therapy with Prolonged Exposure Therapy (PE) compared to PE with placebo (sham) stimulation in participants with posttraumatic stress disorder (PTSD)
Primary Outcome
ReStore System safety by review of any adverse events
Conditions Studied
Interventions
- DEVICE Active VNS stimulation
- DEVICE Sham VNS stimulation
Study Locations (3)
Texas
- The University of Texas Health Austin Ambulatory Surgery Center - Austin
- Baylor University Medical Center - Dallas
- Texas Biomedical Device Center - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-30 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT06266364 shows while recruiting
NCT06266364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 278-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (93% lower).
The record links to 1 condition, with PTSD - Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active VNS stimulation is the first listed.
NCT06266364 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06266364 about?
NCT06266364 is a clinical study titled "Targeted Plasticity Therapy for PTSD". Objectives of this study are to provide continued safety assessment for the ReStore system, and to gain further estimates of the effect size of Vagus Nerve Stimulation (VNS) therapy with Prolonged Exposure Therapy (PE) compared to PE with placebo (sham) stimulation in participants with posttraumatic...
What is the current status of trial NCT06266364?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-12-30. Estimated completion is 2028-06.
What conditions does trial NCT06266364 study?
This clinical trial studies the following conditions: PTSD - Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT06266364?
The interventions under investigation include: Active VNS stimulation (DEVICE), Sham VNS stimulation (DEVICE).
Who is sponsoring clinical trial NCT06266364?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06266364 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD - Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06266364's enrollment target sits among peer trials
20 13th of 14 higher than 1 of 14 other PTSD - Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD - Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Diet and Microbiome Interactions: Application in Posttraumatic Stress Disorder in Adults Consuming Vegetable Drinks
RECRUITING · NA
-
Transcranial Magnetic Stimulation in Veterans With PTSD
RECRUITING · NA
-
Empowering Perinatal Adolescents Through Writing
RECRUITING · NA
-
Restorative Early Sleep Treatment After the Emergency Department
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI